Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company ...
Staphylococcus aureus is a type of bacteria. It stains Gram positive and is non-moving small round shaped or non-motile cocci. It is found in grape-like (staphylo-) clusters. This is why it is called ...
Asianet Newsable on MSN
Armata Pharmaceuticals Stock Soars To Record High After Phage Therapy Data In Deadly Infection Trial; Retail Traders Pile In
The company’s bacteriophage therapy AP-SA02 achieved an 88% response rate in a Phase 2a trial for Staphylococcus aureus ...
Around 20 percent of all humans are persistently colonized with Staphylococcus aureus bacteria, a leading cause of skin infections and one of the major sources of hospital-acquired infections, ...
Since the 1940s, antibiotics have been our primary weapon against harmful bacterial infections. But some stubborn pathogens, ...
Lakewood-Amedex Biotherapeutics Inc., a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, ...
This study explored the resistance mechanisms of Staphylococcus aureus (S. aureus) to novobiocin, a gyrB inhibitor. Through adaptive laboratory evolution, key resistance mutations (in gyrB, potB, and ...
Fourteen people fell sick in a Staphylococcus aureus outbreak in China after eating contaminated donkey and goose meat. In ...
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback